Integrate transcriptional Drug and Disease Signatures to predict therapeutic compound combinations http://synergyseq.com/ (https://schurerlab.shinyapps.io/synergyseq/)
Stathias, V., Jermakowicz, A.M., Maloof, M.E., Forlin, M., Walters, W., Suter, R.K., Durante, M.A., Williams, S.L., Harbour, J.W., Volmar, C.H., et al. (2018). Drug and disease signature integration identifies synergistic combinations in glioblastoma. Nature Communications 9, 5315
This research was supported by grant U54HL127624 awarded by the National Heart, Lung, and Blood Institute through funds provided by the trans-NIH Library of Integrated Network-based Cellular Signatures (LINCS) Program (http://www.lincsproject.org/) and the trans-NIH Big Data to Knowledge (BD2K) initiative (https://datascience.nih.gov/).